you are here:

Syncom Formulations Ltd.

BSE Live

Aug 05, 16:00
7.27 -0.25 (-3.32%)
Volume
AVERAGE VOLUME
5-Day
3,298,643
10-Day
3,332,720
30-Day
3,656,700
2,362,890
  • Prev. Close

    7.52

  • Open Price

    7.52

  • Bid Price (Qty.)

    7.24 (14270)

  • Offer Price (Qty.)

    7.26 (2836)

NSE Live

Dec 27, 11:22
NT* 0.00 (0.00%)
Volume
No Data Available
0
  • Prev. Close

    -

  • Open Price

    -

  • Bid Price (Qty.)

    - (0)

  • Offer Price (Qty.)

    - (0)

Syncom Formulations is not listed on NSE

ANNOUNCEMENTS ON Syncom Formula

  • Jul 28, 2021 20:13 Source: BSE

    Syncom Formulations - Submission Of Disclosure Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015 Regarding Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2021.

    Pursuant to Regulation 23(9) of SEBI (LODR) Regulations, 2015 as amended from time to time, we are pleased to submit the Disclosure of Statement of Related Party Transactions for the half year ended 31st March, 2021. The same is also published on the website of the Company www.sfil.in You are requested to please consider and take on record the same.

  • Jul 20, 2021 14:42 Source: BSE

    Syncom Formulations - Shareholding for the Period Ended June 30, 2021

    Syncom Formulations India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here

  • Jul 20, 2021 13:23 Source: BSE

    Syncom Formulations - Statement Of Investor Complaints For The Quarter Ended June 2021

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
    0000
    Name of the Signatory :- Vijay Shankarlal Bankda
    Designation :- Managing Director / Whole Time Director

  • Jul 12, 2021 20:20 Source: BSE

    Syncom Formulations - Announcement under Regulation 30 (LODR)-Newspaper Publication

    SUBMISSION OF PRESS CLIPPING RELATED TO STATEMENT OF DEVIATION/VARIATIONS IN UTILIZATION OF FUNDS RAISED THROUGH PREFERENTIAL ISSUE.

  • Jul 02, 2021 11:52 Source: BSE

    Syncom Formulations - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 30 read with Schedule III Part A(A)and in compliance of Regulation 47(1)(b) of SEBI (LODR) Regulations, 2015 regarding extract of Standalone Audited Quarterly and Year to Date Financial Results for the Quarter/Year ended 31st March, 2021 was approved in 01/2021-22 Meeting of Board of Directors held on Wednesday, 30th June, 2021 at 4.00 P.M. at the Corporate Office of the Company at 207, Saket Nagar, Indore (M.P.) 452018. We herewith enclosed the newspaper advertisement published on 02/07/2021 in Free Press Journal English edition and Marathi (vernacular) Newspaper.

  • Jul 02, 2021 11:50 Source: BSE

    Syncom Formulations - Corrigendum To The Submission Of The Audited Financial Results Along With Auditors' Report Thereon For The Quarter/Year Ended 31St March, 2021 As Per Regulation 33(3)(D) Of SEBI (LODR) Regulations, 2015.

    Dear Sir/Ma'am, This is in continuation of our letter no. SYNCOM/SE/2021-22 dated 30th June, 2021 regarding Submission of the Audited Financial Results along with Auditors' Report thereon for the Quarter/Year ended 31st March, 2021 as per Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015. We are extremely sorry to inform that due to Typical error in the statement of Assets and Liabilities as at 31.03.2021 as under; (i) in the heading of Non Current Assets- Trade Receivable of Rs. 770.40 be considered as Nil; (ii) in the heading of Non Current Assets - Deposits of Rs. 33.75 be considered as Rs. 804.15; We further submit the Audited Financial Results for the quarter/year ended 31st March, 2021 along with Auditor's Report for your reference and record. You are requested to take on record and upload at the portal of BSE for your reference and record.

  • Jun 30, 2021 21:21 Source: BSE

    Syncom Formulations - Submission Of The Statement Of Deviation Pursuant To Regulation 32(1) For The Quarter Ended 31St March, 2021 As Per SEBI (LODR) Regulations, 2015.

    We are pleased to submit Statement of raising of funds against the total project cost of Rs. 4031.00 Lakhs to meet the cost of the expansion of the Injectable capacity from 200.00 Lakhs to 300.00 Lakhs per annum and modernization of the Tablet Department project being carried at Pithampur Unit. The Company has issued convertible 15,93,47,820 warrant of Rs. 2.53 convertible into equity shares of Rs. 1/- each at a premium of Rs. 1.53 per share. Out of which the Company has generated funds during the quarter ended 31stMarch, 2021 as under; 1. Upfront amount at the time of issuance of warrants on 25.01.2021 Rs. 1035.76 Lakhs 2. Conversion amount of First Trench for 93,00,000 Warrants on 27.03.2021 Rs. 174.84 Lakhs. There is no modification in the project and the fund utilized against the actual funds raised for the quarter ended 31stMarch, 2021 is enclosed herewith. You are requested to take on record the same for your reference and record.

  • Jun 30, 2021 21:13 Source: BSE

    Syncom Formulations - Submission Of The Standalone Audited Financial Results Along With Auditors' Report Thereon For The Quarter/Year Ended 31St March, 2021 As Per Regulation 33(3)(D) Of SEBI (LODR) Regulations, 2015.

    Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Audited Financial Results along with Auditors' Report thereon by Statutory Auditors for the quarter/year ended on 31st March, 2021, in PDF Format, which were also approved by the Audit Committee and Board of Directors at their meeting held on Wednesday, 30th June, 2021. Since, the Auditor's Report is self-explanatory and has no modification/qualification; it needs no further comments by the Company. We are also in process to file the aforesaid financial results in XBRL format within the stipulated time and same shall also be hosted at the website of the company www.sfil.in. The Financial Results will also be published in widely circulated English & Marathi (Vernacular) newspaper in the prescribed format for that purpose. You are requested to take on record the Audited Financial Results, along with Auditor's Report for your reference and record.

  • Jun 30, 2021 10:55 Source: BSE

    Syncom Formulations - Closure of Trading Window

    We would like to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015 read with BSE circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019; the window for trading in the shares of the Company shall remain closed from 1st July, 2021 till completion of 48 hours after the declaration of the unaudited Financial Results for the quarter ended on 30th June, 2021. All the Directors, KMP's, Designated Employees, connected persons, fiduciaries and their immediate relatives are advised not to deal in the shares of the Company either directly or indirectly during the aforesaid period. The date of meeting of the Board of Directors to approve the unaudited financial results of the Company for the Quarter ended on 30th June, 2021 will be informed in due course. You are requested to please take on record above said information for your reference.

  • Jun 23, 2021 15:14 Source: BSE

    Syncom Formulations - Board Meeting Intimation for 01/2021-22 Board Meeting For Consideration And Approval Of The Standalone Audited Financial Results For The Quarter/Year Ended 31St March, 2021.

    SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve 1. To consider & approve the Standalone Audited financial results of the Company for the Quarter/Year ended 31st March, 2021. 2. To take on record the Audit Report of the Statutory Auditors for the Standalone Audited Financial Results of the Company for the Quarter/Year ended 31st March, 2021. 3. To consider and approve the Standalone Audited Financial Statements, including the Balance Sheet, as at 31st March, 2021 and the Statement of Profits and Loss and Cash flow, statement of change in equity and notes thereon for the year ended 31st March, 2021.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Jun 30, 2021
Remark : Audited & Quarterly Results